glp 1 mechanism of action diagram Frontiers Mechanisms of Action and Therapeutic

Note, GLP-1 agonists can be addressed by either 503A or 503B compounding pharmacies

After a 6-month treatment with liraglutide in patients with newly diagnosed type 2 diabetes mellitus a reduced PWV and systolic blood pressure, aortic blood pressure and augmentation index were seen

It is often used by diabetics who are treating low blood sugar levels in some cases

A 2025 retrospective cohort study of 210 T2DM patients on oral semaglutide for 18 months found no significant association between rs6923761 or rs761387 genotypes and changes in HbA1c or BMI in that relatively well-controlled population (Candido et al., 2025) suggesting that receptor-level genotype effects may be detectable primarily in subpopulations with higher pharmacological demand or larger baseline disease severity, rather than as universal predictors